MCF Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.1K | Hold |
120
| – | – | ﹤0.01% | 772 |
|
|
2025
Q4 | $24.8K | Hold |
120
| – | – | ﹤0.01% | 648 |
|
|
2025
Q3 | $21.5K | Hold |
120
| – | – | ﹤0.01% | 575 |
|
|
2025
Q2 | $19.4K | Hold |
120
| – | – | ﹤0.01% | 557 |
|
|
2025
Q1 | $20.4K | Hold |
120
| – | – | ﹤0.01% | 543 |
|
|
2024
Q4 | $19.9K | Hold |
120
| – | – | ﹤0.01% | 557 |
|
|
2024
Q3 | $20.6K | Hold |
120
| – | – | ﹤0.01% | 546 |
|
|
2024
Q2 | $18.5K | Hold |
120
| – | – | ﹤0.01% | 555 |
|
|
2024
Q1 | $18.5K | Hold |
120
| – | – | ﹤0.01% | 545 |
|
|
2023
Q4 | $19K | Hold |
120
| – | – | ﹤0.01% | 509 |
|
|
2023
Q3 | $17.6K | Hold |
120
| – | – | ﹤0.01% | 503 |
|
|
2023
Q2 | $18.4K | Hold |
120
| – | – | ﹤0.01% | 484 |
|
|
2023
Q1 | $18.6K | Hold |
120
| – | – | ﹤0.01% | 480 |
|
|
2022
Q4 | $18.5K | Hold |
120
| – | – | ﹤0.01% | 461 |
|
|
2022
Q3 | $16K | Hold |
120
| – | – | ﹤0.01% | 494 |
|
|
2022
Q2 | $16K | Hold |
120
| – | – | ﹤0.01% | 466 |
|
|
2022
Q1 | $18K | Buy |
+120
| New | +$17.8K | ﹤0.01% | 467 |
|
|
2021
Q4 | – | Sell |
-120
| Closed | -$20K | – | 256 |
|
|
2021
Q3 | $20K | Hold |
120
| – | – | ﹤0.01% | 414 |
|
|
2021
Q2 | $21K | Hold |
120
| – | – | ﹤0.01% | 382 |
|
|
2021
Q1 | $19K | Hold |
120
| – | – | ﹤0.01% | 370 |
|
|
2020
Q4 | $20K | Hold |
120
| – | – | ﹤0.01% | 336 |
|
|
2020
Q3 | $19K | Hold |
120
| – | – | ﹤0.01% | 325 |
|
|
2020
Q2 | $20K | Hold |
120
| – | – | ﹤0.01% | 306 |
|
|
2020
Q1 | $16K | Hold |
120
| – | – | ﹤0.01% | 325 |
|
|
2019
Q4 | $18K | Hold |
120
| – | – | ﹤0.01% | 337 |
|
|
2019
Q3 | $15K | Hold |
120
| – | – | ﹤0.01% | 341 |
|
|
2019
Q2 | $17K | Hold |
120
| – | – | ﹤0.01% | 328 |
|
|
2019
Q1 | $18K | Hold |
120
| – | – | ﹤0.01% | 311 |
|
|
2018
Q4 | $15K | Hold |
120
| – | – | ﹤0.01% | 318 |
|
|
2018
Q3 | $19K | Buy |
+120
| New | +$18.2K | ﹤0.01% | 302 |
|
|
2018
Q2 | – | Sell |
-120
| Closed | -$16K | – | 451 |
|
|
2018
Q1 | $16K | Hold |
120
| – | – | ﹤0.01% | 304 |
|
|
2017
Q4 | $15K | Hold |
120
| – | – | ﹤0.01% | 312 |
|
|
2017
Q3 | $15K | Hold |
120
| – | – | ﹤0.01% | 318 |
|
|
2017
Q2 | $14K | Hold |
120
| – | – | ﹤0.01% | 341 |
|
|
2017
Q1 | $13K | Hold |
120
| – | – | ﹤0.01% | 336 |
|
|
2016
Q4 | $11K | Hold |
120
| – | – | ﹤0.01% | 305 |
|
|
2016
Q3 | $12K | Hold |
120
| – | – | ﹤0.01% | 306 |
|
|
2016
Q2 | $11K | Hold |
120
| – | – | ﹤0.01% | 334 |
|
|
2016
Q1 | $11K | Hold |
120
| – | – | ﹤0.01% | 310 |
|
|
2015
Q4 | $14K | Buy |
+120
| New | +$12.9K | ﹤0.01% | 297 |
|
Other funds holding FBT
BFG
MCF Advisors's FBT Position: Q1 2026 in Review
MCF Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 120 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #772.
MCF Advisors first reported a position in FBT in Q4 2015 and has held it in 40 quarters since. The position peaked at $24.8K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- MCF Advisors held 120 shares of First Trust NYSE Arca Biotechnology Index Fund worth $24.1K as of Q1 2026.
- MCF Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #772 holding.
- MCF Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2015 and has held it in 40 quarters since.
- MCF Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $24.8K in Q4 2025.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.